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LIST OF ABBREVIATIONS 
CAL         -      Clinical Attachment Level 
CD           -     Cluster Differentiation 
Cpn           -     Chaperonin 
CRP       -    C Reactive Protein 
ELISA      -      Enzyme Linked Immuno Sorbent Assay 
GCF         -      Gingival Crevicular Fluid 
GroEL       -     Growth of Escherichia Coli Large 
HSP          - Heat Shock Protein 
HumHSP  -       Human Heat Shock Protein  
ICAM       -       InterCellular Adhesion Molecule 
IFN           -       Interferon  
Ig              -       Immunoglobulin 
IL              -       Interleukin 
LPS           -      Lipopolysaccharide 
MHC        -       Major Histocompatibility Complex 
MMP       -        Matrix Metalloproteinase 
MycHSP  -        Mycobacterial Heat Shock Protein 
NK           -       Natural Killer  
PAMPs     -       Pathogen Associated Molecular Patterns  
PBMC      -        Peripheral Blood Mononuclear Cells 
PBS          -        Phosphate Buffered Saline 
PPD         -        Periodontal Probing Depth 
RA           -        Rheumatoid Arthritis 
RANKL  -         Receptor Activator of Nuclear Factor – κ B Ligand 
STAT       -        Signal Transduction and Activation of Transcription 
T reg        -         Regulatory T Cell 
TCR         -        T Cell Receptor 
TGF         -         Transforming Growth Factor 
Th             -        Helper T Cell 
TLR          -       Toll Like Receptor 
TNF          -        Tumor Necrosis Factor 
VCAM      -       Vascular Cell Adhesion Molecule 
WBC        -        White Blood Cell 
Abstract:- 
Background: 
            Self antigens such as Heat shock protein 60 (HSP 60) have recently been 
implicated in the periodontal disease pathogenesis. There is scant evidence 
regarding HSP 60 in circulation and saliva following periodontal disease and its 
possible relation to systemic inflammation. 
Materials and methods:  
Forty five peripheral blood samples and saliva samples were collected 
from two groups of patients (periodontal health-Group A and periodontal 
disease- Group B). The serum, cell lysates, and saliva samples were used to 
detect and compare the HSP 60 levels in both the groups by Enzyme Linked 
Immuno Sorbent Assay (ELISA) technique. Statistical analysis was done using 
the student t test and Pearson’s correlation.  
Results: 
Circulatory HSP 60 significantly increases in periodontal disease 
compared to health. There was a significant correlation between the total 
circulating HSP 60 but not cell lysate and serum levels in periodontal disease. 
There was no significant association between salivary HSP 60 and periodontal 
disease or systemic inflammation. 
 
Conclusion: 
Circulating HSP 60 levels seem to play role in the systemic inflammatory 
state produced by periodontal disease. Salivary HSP 60 may not be used as a 
surrogate to determine systemic inflammation.                                                                             
Key words:  HSP 60, Periodontitis, Peripheral blood, Cell lysates, ELISA. 
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Periodontitis is defined as an inflammatory disease of the supporting 
tissues of the teeth caused by specific microorganisms or groups of specific 
microorganisms resulting in progressive destruction of the periodontal 
ligament and alveolar bone with pocket formation, recession or both.44 
Porphyromonas gingivalis, a gram negative anaerobic bacteria has been 
strongly implicated in the pathogenesis of chronic periodontitis, either singly 
or in combination with other red complex bacteria such as Tannerella 
forsythia, Treponema denticola.65 The major antigenic determinants of these 
pathogens are Lipopolysaccharides, capsule, fimbriae, outer membranous 
protein; etc.23 Although the inflammatory response in periodontal disease is 
evoked primarily in response to these exogenous antigens, structural 
similarities with host antigens may result in their activating the immune 
system through molecular mimicry.81  
Heat shock proteins (HSP) are perhaps, the most extensively 
investigated self antigens involved in periodontal disease. These proteins  are 
produced by cells in response to stress stimuli, including high temperature, 
mechanical stress, infection, surgical stress, oxidant and cytokine 
stimulation.40 They participate in vital physiological processes in the cell such 
as folding, assembly, and translocation of polypeptides across membranes and 
are hence referred to as molecular chaperones. HSP 60 or Cpn 60 is a 








their respective three-dimensional structure. Human HSP 60 (HumHSP 60) 
and their bacterial counterparts share more than 50% amino acid sequence 
homology, as a result of which the immune system may be inadvertently 
activated against these self antigens.14 
Petit et al ,Ueki et al  have described a role for HSP 60 in periodontal 
disease. These authors have demonstrated an upregulation of HSP 60 
expression in gingival tissues affected by periodontal disease. A potential role 
for these proteins in the etiopathogenic process has also been proposed based 
on the structural similarity between HSP 60 (GroEL) of Porphyromonas 
gingivalis and human gingival fibroblast. HSP 60 was shown to induce 
secretion of proinflammatory cytokines in professional antigen presenting 
cells.79,27 HSP 60 increases the activation of T cells in primary stimulation and 
thereby perpetuates the overall inflammatory process.79  
HSP 60 has been identified in serum even though they are typically 
regarded as intracellular components. 56 The source of this freely circulating 
HSP 60 is not fully understood and has hence, been the object of much 
speculation among some investigators.57 Regardless of the source; circulating 
HSP 60 levels may assume clinical significance because it has been implicated 
in the etiopathogenesis of cardiovascular disease. HSP 60 has been reported to 
upregulate  E-selectin, ICAM 1, VCAM 1 expression and interleukin 6 









 It is not yet known if periodontal disease contributes to this circulating 
HSP 60 although there is some evidence of a systemic spill over of several 
inflammatory mediators.25 It is also not clear if circulating HSP 60 contributes 
to the systemic inflammation observed in periodontal disease, as evidenced by 
increased hs CRP levels. 
 Saliva has been used as a diagnostic tool to investigate periodontal 
disease activity as it is readily available and contains locally produced 
microbial and host response mediators.54 Saliva can be collected noninvasively 
in large amounts, & with less patient discomfort, when compared to gingival 
crevicular fluid.31 Several inflammatory markers and host derived products in 
saliva such as IL-1, TNF α, MMPs, human neutrophil elastase, etc have been 
evaluated for use as markers for periodontal disease activity.39,70  However 
there is scant literature regarding the use of salivary HSP 60 as a biomarker. 
 In recent years saliva has been postulated to be capable of reflecting 
not only periodontal disease but also systemic diseases such as, 
Cardiovascular disease54  Rheumatoid arthritis, Sjogrens syndrome.11 There is 
insufficient evidence in literature regarding the reliability of using saliva as a 
surrogate for evaluating systemic inflammatory status and its mediators.21 
The purpose of this study is to estimate circulatory and salivary levels 
of HSP 60 in periodontal disease and to assess whether they correlate with 
each other and with the systemic inflammatory status. 
 
 





AIMS AND OBJECTIVES 
 The objectives of the present study are, 
1) To estimate the circulatory levels of HSP 60 in periodontal health 
and disease. 
2) To identify whether circulating HSP 60 levels correlate with hs 
CRP in periodontal disease. 
3) To estimate the salivary levels of HSP 60 in periodontal health and 
disease. 










REVIEW OF LITERATURE 
Periodontal disease is characterised as a peripheral infection involving 
multiple species of gram negative organisms. The pathogenic species present 
in sub gingival biofilm release an array of virulence factors that can evade 
antibacterial host defence mechanisms and then cause damage to host tissue 
via immune or inflammatory interactions, which typically consist of  
neutrophils, monocytes/ macrophages, T cells and B cells. 
Socransky & Haffajee 1990 65 proposed the presence of complexes of 
bacteria residing  in dental plaque of which the red complex( Porphyromonas 
gingivalis, Tannerella forsythia, Treponema denticola) are thought to be 
closely associated with pathogenesis of periodontal disease.  
These red complex bacteria are involved in the production of many 
virulence factors, such as capsule, Lipopolysaccharide, fimbriae, GroEL heat 
shock protein, outer membranous protein of gram negative bacteria. These 
antigens are believed to result in activation of host immune and inflammatory 
responses, which involves the generation of cytokines, recruitment of 
inflammatory cells, and the activation of osteoclasts. 
It has recently been recognized, that many pathogens express virulence 
genes only when they are in their human or animal host. Handfield and 
coworkers 23  described an ingenious approach to distinguishing such 
 
 





virulence factors. If a specific virulence factor were to play a role in the 
pathogenesis of infectious diseases, then that factor would be likely to elicit an 
antibody response in an individual with the disease which would not be 
observed in serum samples from subjects who did not have the disease. Using 
these techniques, there is increasing evidence regarding the role of self 
antigens in periodontal disease.   
Role of self antigens in periodontal disease:- 
In recent years it has been recognized that the immune response to self 
antigens may contribute to the disease process. High titres of anti collagen 
type I antibody have been identified in sera and collagen type specific T cell 
clones can be identified in infected gingival tissues in periodontitis.  
Exogenous antigens may themselves help to elicit responses from host 
self antigens in the following way. An exogenous antigen may present with 
structural similarities with certain host antigens; thus, any antibody produced 
against this antigen (which mimics the self – antigens) bind to the host 
antigens and amplify the human response. The most striking form of 
molecular mimicry is observed in Group B-hemolytic streptococci, which 









The immune system can fail in one of three ways. 
1. Mistaken recognition of self antigens – autoimmunity 
2. An ineffective immune response – immunodeficiency. 
3. An overactive immune response – hypersensitivity. 
An essential requisite for the immune system is the ‘Immunological 
Tolerance’, which is the ability of an individual to differentiate ‘self’ from 
‘non-self’. This breakage leads to the Immune System mounting an effective 
and specific immune response against self determinants. The exact genesis of 
immunological tolerance is still elusive, but several theories have been 
proposed since the mid-twentieth century to explain its origin. There are three 
hypotheses in this regard,  
• Clonal deletion theory, proposed by Burnet, according to which self 
– reactive lymphoid cells are destroyed during the development of the 
immune system in an individual. 
• Clonal Anergy theory, proposed by Noooal, in which self – reactive 
T or B cells become inactivated in the normal individual and cannot 
amplify the immune response. 
• Idiotype Network theory, proposed by Jerne, wherein a network of 
antibodies capable of neutralizing self-reactive antibodies exists 
naturally within the body. 
 
 





Tolerance can also be differentiated into ‘central’ and ‘peripheral’ 
tolerance, on whether or not the above checking mechanisms operate in the 
central lymphoid organs (Thymus and Bone marrow) or the peripheral 
lymphoid organs (lymph node, spleen etc., where self-reactive B-cells may be 
destroyed).If these tolerance mechanisms are  attenuated/reset;   then the host 
antigens start acquiring a pathogenic character. 
Molecular mimicry between bacterial and HumHSP may allow 
microorganisms to evade the host defenses. Immune responses to bacterial 
HSP may generate cross reacting immunity to self-HSP and precipitate 
damaging inflammatory responses   
Three models have been proposed to link microbial infections to 
subsequent autoimmune reactions involving HSP These models are based on 
(i) molecular mimicry between microbial HSP and HumHSP or constitutive 
proteins from the host, (ii) inflammation-induced exposure of cryptic cell 
epitopes that could be a target for immune reactions, and (iii) antigen 
persistence in infected sites leading to chronic immunological reactions. 
Major periodontopathic bacteria such as Porphyromonas gingivalis, 
Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, 
Prevotella intermedia , Tannerella forsythia, and Campylobacter rectus are 
reported to produce HSP homologous to Escherichia coli GroEL. Bacterial 
HSP 60 ,termed GroEL, are major antigenic determinants during infection, 
and since human and bacterial HSP 60 have a 55% homology, it is possible 
 
 





that immune response to bacterial challenge may result in cross reactivity by 
targeting host cells expressing HumHSP 60. 
Heat Shock Protein 60 and periodontal disease:- 
Heat shock proteins (HSP) are grouped in families according to their 
molecular mass, and the human and bacterial cognates are very similar, 
sharing more than 50% sequence homology at the amino acid level.  
In response to stress stimuli, including high temperature, mechanical 
stress, infection, surgical stress, and oxidant and cytokine stimulation, cells 
produced high levels of Heat shock protein to protect themselves against these 
unfavourable conditions40 They participate in vital physiological processes in 
the cell such as folding, assembly, and translocation of polypeptides across 
membranes and play a role in protein repair after cell damage. 
HSP 60 or Cpn 60 is a mitochondrial chaperonin that functions as a 
chaperonin to assist in folding linear amino acid chains into their respective 
three-dimensional structure. HSP 60 has been shown to be released from 
specific cells like peripheral blood mononuclear cells (PBMCs) when there are 
lipopolysaccharides (LPS) or GroEL present. This suggests that the cell has 
different receptors and responses to human and bacterial HSP 60.  In addition, 
it has been shown that HSP 60 has the capability of activating monocytes, 
macrophages and dendritic cells and also of inducing secretion of a wide range 
of cytokines.                           
 
 





The HSP 60 was shown to induce a secretion of proinflammatory 
cytokines in professional antigen presenting cells and to enhance the activation 
of T cells in primary stimulation. HSP 60 is expressed on the surface of 
different eukaryotic cell lines increases the activation of T cells in primary 
stimulation. Although heat shock proteins are typically regarded as being 
intracellular they can be expressed on the surface of mononuclear cells77 and 
HSP 60 has been identified in serum of healthy individuals56  
A significant temperature elevation up to 2°C is observed in inflamed 
periodontal pocket. Moreover, it is known that several pro-inflammatory 
immune mediators are produced in the inflamed periodontal tissue. These 
stressors might cause an upregulation of endogenous HSP in the periodontal 
tissue of periodontitis patients.  
Lundqvist C et al. (1994)38 found the expression of HSP 60 to be 
higher in gingival epithelial cells of inflamed tissue samples from periodontitis 
patients compared with samples from periodontally healthy individuals.    
          Ando T et al. (1995)2 demonstrated that the serum from a periodontitis 
patient, contained antibodies that reacted with A actinomycetemcomitans, F. 
nucleatum, and P. nigrescens HSP 60 and/or HSP 70, suggesting that these 
proteins may be involved in the pathogenesis of periodontitis. 
          M.D.A. Petit et al 1999 53 investigated the proliferative responses of 
PBMCs of patients with periodontitis (n = 10) and controls with gingivitis(n = 
 
 





12) to recombinant mycobacterial HSP 60 (MycHSP60) and HSP 70 
(MycHSP70), as well as recombinant human HSP 60 (HumHSP60) and HSP 
70 (HumHSP70) and also the proliferative responses to Candida albicans and 
purified protein derivatives of Mycobacterium (PPD). Mean responses to 
HumHSP 60, MycHSP 60, and HumHSP 70, MycHSP 70 were significantly 
lower for patients compared with controls. The level of IFN-γ in the 
supernatants of the cells stimulated with HSP’s was lower in the patients 
compared with controls. This concurs with the current hypothesis that 
periodontitis patients have a depressed Thl response. He found that with an 
increasing estimated subgingival bacterial load, periodontitis patients mount a 
decreasing immune response to HSPs, and the poor reactivity to HSPs may be 
a susceptibility factor for destructive periodontal disease and may need to be 
considered in the pathogenesis of this condition. 
Tabeta K et al. (2000)69 reported that gingival tissue extracts from 
healthy or periodontitis patients contain antibodies to the GroEL protein of 
Porphyromonas gingivalis. They also demonstrated that diseased periodontal 
tissues reacted more strongly to Porphyromonas gingivalis GroEL and human 
HSP 60 compared with healthy controls. The authors showed that periodontitis 
patients had a higher antibody titer against Porphyromonas gingivalis GroEL 
than did healthy subjects.  
K. Ueki (2002)73  demonstrated  that serum antibodies to both 
HumHSP 60 and Porphyromonas gingivalis GroEL were elevated in 
 
 





periodontitis patients compared with healthy subjects. The stimulatory effect 
of human and bacterial HSP 60 on the production of tumour necrosis factor-α 
(TNF-α) was examined in phorbol myristate acetate stimulated THP-1 
cells(Human monocytic cell line). The activity of HSP 60 was inhibited by 
anti-CD14 and anti-Toll-like receptor 4 (TLR4) antibodies, suggesting that 
both CD14 and TLR4 mediate HSP 60 signalling. Immunohistochemical 
analysis demonstrated that HSP 60 is abundantly expressed in periodontitis 
lesions. Therefore, it is postulated that periodontopathic bacteria stimulate the 
cells in the periodontium to up-regulate the expression of HSP 60, which in 
turn may stimulate macrophage and possibly other cells to produce 
proinflammatory cytokines. These mechanisms may be involved in the 
chronicity and tissue destruction of periodontal disease. 
Hsp60 & immune Response in periodontal disease 
Immune responses to bacterial HSP may generate cross reacting 
immunity to self-HSP and precipitate damaging inflammatory responses. 
Endogenous rather than bacterial HSP are more likely to be involved in 
signalling innate responses in periodontal disease. 
Human but not periodontopathic bacterial HSP 60 can induce TNF-α 
production in macrophages and this activity is mediated at least in part by 
CD14 and TLR4, both of which are known to be LPS receptors. Bacterial 
homologue of HumHSP60, Porphyromonas gingivalis GroEL and 
Aggregatibacter actinomycetemcomitans GroEL did not show TNF-α inducing 
 
 





activity.  Proinflammatory cytokine production induced by autologous HSP 60 
could be another pathway leading to periodontal tissue destruction. 
Petit MD et al. (1999)53 demonstrated that the level of IFN-γ 
production was significantly lower in the periodontitis group than in the 
control group.  NK T cells are recruited to down-regulate the autoimmune 
response against self-components such as HSP 60 
Argueta JG et al (2006 )4 investigated whether the Toll-like receptor 
(TLR) family plays a functional role as a Porphyromonas gingivalis GroEL 
receptor. Human macrophage-like THP-1 cells (Human monocytic cell line) 
were used and the nuclear factor-κB (NF-κB) activity of cells stimulated with 
a recombinant Porphyromonas gingivalis GroEL was measured with a 
luciferase assay. Flow cytometry analysis was used to determine the binding to 
THP-1 cells of fluorescein isothiocyanate (FITC)-labeled GroEL. He observed 
by luciferase assay that the purified recombinant GroEL was able to stimulate 
NF-κB transcriptional activity in THP-1 cells. Flow cytometry analysis 
showed that the FITC-labeled GroEL bound to THP-1 cells in a dose-
dependent fashion. He concluded that Porphyromonas gingivalis GroEL 
induces its intracellular signaling cascade in Th1 cells via TLR2 or TLR4 and 
via a combination of both receptors. 
Fukui M et al (2006)20 stated that Salivary IgA to GroEL may have a 
protective role by reducing the inflammatory response induced by GroEL 
derived from periodontopathogenic bacteria. 
 
 





Yamazaki K et al (2002)80 demonstrated that HSP 60-specific T cells 
accumulated in the gingival lesions of periodontitis patients but not in 
gingivitis patients and that the T cell clones with an identical specificity to 
those in peripheral blood existed in periodontitis lesions. 
Choi JI et al (2004)9 showed that Porphyromonas gingivalis HSP 
reactive T cell immune response might be involved in immunopathogenesis of 
periodontal disease. They suggested that T cells in the circulating peripheral 
blood may home to periodontal lesions where Porphyromonas gingivalis have 
infiltrated potentially leading to T cell response cross reactive to mammalian 
HSP of gingival fibroblasts. 
Wassenar A et al (1995)76 described the cloning and characterization 
of CD4  and CD8 T lymphocytes isolated from inflamed gingival tissue 
obtained from four patients with chronic periodontitis. Clones were raised 
with phytohemagglutinin and interleukin-2 and tested for proliferation in 
response to whole-cell antigens of Porphyromonas gingivalis, Prevotella 
intermedia, Actinobacillus actinomycetemcomitans, human collagen type I, 
and two bacterial heat shock proteins using flow cytometry analysis. Most 
clones were reactive with P. intermedia, it seems that the immune response is 
not strictly directed against this particular microorganism, as clones reactive 
with one of the other bacteria were also obtained from two patients. He 
proposed that collagen-specific CD4 Th2-like T cells contribute to the 
chronicity of periodontitis but that their modes of activation might be 
 
 





controlled by Th0-like T cells specific for periodontitis-associated bacteria, 
suggesting that autoimmune component might be involved in the pathogenesis 
of periodontitis. 
Yamazaki K, Ohsawa Y, Yoshie H. et al (2001) 81 showed that immune 
responses to auto antigens such as collagen Type I or HSP 60 is controlled by 
NK T cells through CD1 expression. 
K Yamazaki, (2004)82 determined whether periodontal treatment could 
influence the level of serum antibodies to HumHSP 60 and Porphyromonas 
gingivalis GroEL. Sera were obtained from 21 patients with moderate to 
advanced chronic periodontitis at the baseline examination and again after 
completion of treatment. Antibody levels were determined using an ELISA. 
The mean anti-P. gingivalis GroEL antibody levels were down-regulated 
significantly by periodontal treatment. The mean level of anti-human HSP60 
antibody remained unchanged although individual levels of antibody either 
increased or decreased after periodontal treatment, suggesting that synthesis of 
these antibodies might be regulated independently during the course of 
periodontal infection. 
 Kazuhisa Yamazaki,(2004)79  he examined the proliferative response 
of peripheral blood mononuclear cells (PBMC), as well as the cytokine profile 
and T-cell clonality, for periodontitis patients and controls following 
stimulation with recombinant HumHSP 60 and Porphyromonas gingivalis 
GroEL. The nucleotide sequences within complementarity-determining region 
 
 





3 of the T-cell receptor (TCR) chain were compared between HSP 60-reactive 
peripheral blood T cells and periodontitis lesion-infiltrating T cells. 
Periodontitis patients demonstrated significantly higher proliferative responses 
of PBMC to HumHSP 60, but not to Porphyromonas gingivalis GroEL, than 
control subjects. The response was inhibited by anti-major histocompatibility 
complex class II antibodies. Analysis of the nucleotide sequences of the TCR 
demonstrated that HumHSP 60 - reactive T-cell clones and periodontitis 
lesion-infiltrating T cells have the same receptors, suggesting that HSP 60-
reactive T cells accumulate in periodontitis lesions. Analysis of the cytokine 
profile demonstrated that HSP 60-reactive PBMC produced significant levels 
of gamma interferon in periodontitis patients, whereas Porphyromonas 
gingivalis GroEL did not induce any skewing toward a type1 or type 2 
cytokine profile. He suggested that periodontitis patients have HumHSP 60 -
reactive T cells with a type 1 cytokine profile in their peripheral blood T-cell 
pools. 
Ford P et al (2005)18 examined the nature of the inflammatory 
infiltrate and the presence of HumHSP 60 and GroEL in 31 carotid 
endarterectomy specimens. HumHSP 60 expression was evident on 
endothelial cells and cells with the appearance of smooth muscle cells and 
lymphocytes  
T. Honda (2006)27 compared the gene expression profile of 
inflammatory mediators including proinflammatory cytokines and other 
 
 





inflammatory molecules, and anti-inflammatory cytokines by using 
quantitative real-time polymerase chain reaction in gingivitis and periodontitis 
lesions. Interleukin (IL)-1β, interferon (IFN)-γ and RANKL, Transforming 
growth factor (TGF)-β1 tended to be higher in periodontitis, whereas tumour 
necrosis factor (TNF)-α and IL-12 , P 40, IL-10 and IL-4  showed no 
difference. Heat-shock protein 60 (HSP60) expression was up-regulated 
significantly in periodontitis. He concluded that autoimmune response to HSP 
60 may exert in periodontitis lesion, and suggest that perhaps subtle 
differences in the balance of cytokines may result in different disease 
expression. 
Jarjour WN  et al (1991)28, who suggested that the difference in the 
levels of anti-HSP antibodies seen in sera of patients with various rheumatoid 
and other inflammatory diseases compared to normal controls, could merely 
reflect disease-associated polyclonal B cell activation. Subsequent 
investigations have suggested that such antibodies or specific T cells against 
HSP were associated with immune and autoimmune diseases.  
K Tabeta (2000)68 examined the presence of antibodies to the 60-kD 
human and Porphyromonas gingivalis GroEL HSP 60 in the sera and inflamed 
gingival tissues of periodontitis patients. Western blot analysis clearly 
demonstrated that the number of periodontitis patients showing a positive 
response to  Porphyromonas gingivalis GroEL and it was higher than the 
number of periodontally healthy subjects. For HumHSP 60, a higher frequency 
 
 





of seropositivity was found in the periodontitis patients than in the healthy 
subjects. In addition, the periodontitis patients demonstrated stronger 
reactivity compared with the healthy subjects. Quantitative analysis of serum 
antibodies by ELISA also demonstrated that the levels of antibodies in the sera 
of patients were significantly higher than those of control subjects. He 
suggested that molecular mimicry between GroEL of the periodontopathic 
bacterium Porphyromonas gingivalis and autologous HumHSP 60 may play 
some role in immune mechanisms in periodontitis. 
Young RA and Elliott TJ  (1989) 83 showed that through these cross-
reactive epitopes, T-cells with specificity for self-HSP can be activated during 
infection. Indeed, conserved HSP epitopes may trigger self-HSP reactive T-
cells, with disease-suppressive regulatory potential.                       
Methods of Hsp60 Detection in Periodontitis 
The increasing interest in HSP as markers of exposure to 
environmental stress or diseases requires a generally applicable method for 
HSP determination. There are many Classical methods that evaluate HSP at 
the protein level 
Enzyme-linked immunosorbent assay 
 It is a biochemical technique used mainly in immunology to detect the 
presence of an antibody or an antigen in a sample.  In ELISA an unknown 
amount of antigen is affixed to a surface, and then a specific antibody is 
 
 





washed over the surface so that it can bind to the antigen. This antibody is 
linked to an enzyme, and in the final step a substance is added that the enzyme 
can convert to some detectable signal.  
Performing an ELISA involves at least one antibody with specificity 
for a particular antigen. The sample with an unknown amount of antigen is 
immobilized on a solid support (usually a polystyrene microtiter plate) either 
non-specifically (via adsorption to the surface) or specifically (via capture by 
another antibody specific to the same antigen, in a "sandwich" ELISA).  
After the antigen is immobilized the detection antibody is added, 
forming a complex with the antigen. The detection antibody can be covalently 
linked to an enzyme, or can itself be detected by a secondary antibody which 
is linked to an enzyme through bioconjugation. 
Between each step the plate is typically washed with a mild detergent 
solution to remove any proteins or antibodies that are not specifically bound. 
After the final wash step the plate is developed by adding an enzymatic 
substrate to produce a visible signal, which indicates the quantity of antigen in 
the sample. Older ELISAs utilize chromogenic substrates, though newer 
assays employ fluorogenic substrates enabling much higher sensitivity. ELISA 
is used to detect serum antibodies to periodontal pathogens and has been used 
in recent studies to quantify specific pathogens.                
 
 





Handley HH et al (1995) 24 has examined by ELISA the serum IgG 
antibody levels to McyHSP 65  and HumHSP 60, as well as to the 
Escherichia coli HSP 60, GroEL, in patients with Rheumatoid arthritis, 
Systemic lupus erythematosus (SLE), Reiter’s syndrome, active tuberculosis, 
and normal controls. 
            Tabeta K et al (2001)69  demonstrated the presence of antibodies to the 
HSP 60 of Actinobacillus actinomycetemcomitans in the sera of periodontitis 
patients and periodontally healthy control subjects by enzyme-linked 
immunosorbent assay using a recombinant A. actinomycetemcomitans GroEL 
as an antigen. 
            Watanabe S et al (2003)76 established an ELISA system to measure 
anti-HSP 60 IgG and IgA antibody titer in sera of Rheumatoid arthritis 
patients 
            Goretzk Li et al (2006) 22 stated that immunoassays for the 
quantification of the HSP biological markers help to define more precisely the 
significance of heat shock proteins in cancer.  
          Shamaei-Tousi A et al (2007)63  measured plasma levels of HSP10, 









Western Blot / Immunoblotting 
Many authors have demonstrated the expression of human and 
bacterial HSP 60 by western blot 64,55,36,37,2,74  It is a powerful method for 
detecting a particular protein in a complex mixture which combines the 
superior resolving power of gel electrophoresis, the specificity of antibodies, 
and the sensitivity of enzyme assays.  This multistep procedure is commonly 
used to separate proteins and then identify a specific protein of interest. Two 
different antibodies are used in this method, one specific for the desired 
protein and the other linked to a reporter enzyme. It is a technique for the 
analysis of proteins within the cell. Proteins are electrophoresed through a 
SDS polyacrylamide gel so as to separate the molecules according to size, and 
are then transferred to a membrane and hybridized with an antibody against 
the specific protein of interest.                       
Systemic inflammatory response in periodontal disease:- 
Chronic periodontal infections are associated with systemic changes to 
blood and blood forming organs. Periodontal disease is capable of 
predisposing to vascular disease given the abundance of gram negative species 
involved, easily detectable levels of proinflammatory cytokines, dense 
immune cell infiltrate involved, association of peripheral fibrinogen and white 
cell count, extent and chronicity of disease. 
 
 





Lipopolysaccharide is released as extra cellular blebs from micro 
organisms within the periodontal pocket and may enter diseased periodontium. 
Bacteraemia may result in free LPS from periopathogenic bacteria being 
present in plasma. Bacteraemia results in gram negative micro organisms 
entering the circulation, where they might activate leucocytes, platelets or 
endothelium directly.  
It has been hypothesised that certain individuals may respond to a 
microbial challenge with an over exuberant or hyper reactive inflammatory 
response. This may be demonstrated by an increase in release of 
proinflammatory mediators when challenged by bacterial LPS. Peripheral 
blood monocytes from such individuals secrete 3-10 times more inflammatory 
mediators in response to bacterial LPS than normal individuals. 
According to Kinane DF and Lowe GDO (2000)32 Hyper reactive 
mononuclear phagocyte expression may be constitutive in susceptible 
individuals or may be induced in those with infections such as periodontal 
disease. Patients with periodontitis have peripheral monocytes that, when 
reacting with LPS give increased prostaglandin production. Hyper 
responsiveness may be induced by persistent infection of the periodontium, 
and this may have a role in the mechanistic link between periodontitis and 
atheroma formation.  
 
 





Periodontitis can elicit a systemic inflammatory response by activating 
the hepatic acute phase response. This occurs presumable as a consequence of 
systemic appearance of transient and recurrent bacteremia of oral origin, 
which has been a long recognised characteristic of periodontal infections.  
Offenbacher S et al (1998)46 hypothesised that gram negative 
anaerobe pathogens from periodontium trigger release of biologically active 
mediators such as PGE2, and TNFα in circulation causing premature labour. 
According to Williams RC, Offenbacher Sl (2000)47 Cross sectional 
evidence indicates that periodontitis elicits a mild elevation in markers of 
acute phase response including C reactive protein, haptoglobin, alpha 1 
antitrypsin, and fibrinogen. The liver in response to systemic challenge of 
organisms secretes acute phase proteins. This acute phase response is triggered 
by blood borne oral LPS and oral bacteria which elicit release of cytokines IL-
6, TNF α. Markers of acute phase response associated with periodontitis and 
cardiovascular risk include C reactive protein, increase in WBC count, and 
increase in α1 anti trypsin, haptoglobin and fibrinogen and decrease in 
albumin 
Noack B  et al (2001)45 determined that CRP plasma levels are 
increased in periodontitis. Also, there are elevated levels of CRP associated 
with infection with subgingival organisms often associated with periodontal 
disease, including Porphromonas gingivalis, Prevotella Intermedia, 
Campylobacter rectus, Bacteriodes forsythus.  
 
 





Havemose-Poulsen A et al (2005)25 reported an increase in the 
proinflammatory cytokines including IL-1α, IL-1β, IL-RA, IL-6, IL-10, TNF α 
levels in systemic circulation following periodontal disease 
Periodontal disease and circulating HSP 60 levels:- 
T-cell immune responses specific to bacterial or HumHSP 60 have 
been demonstrated in atherosclerosis. The host immune system primed by 
HSP of a major periodontal pathogen, such as Porphyromonas gingivalis, can 
cross-react with its cognate mammalian counterpart in gingival connective 
tissue or arterial walls.  
Wand-Wurttenberger A, (1991)77 demonstrated that although HSP are 
typically regarded as being intracellular, they can be expressed on the surface 
of mononuclear cells  and stressed aortic endothelial cells. 
Roman Kleindienst, in (1993)33 demonstrated that the intensity of HSP 
60 expression correlates positively with the atherosclerotic severity and that 
most lymphocytes participating in atherogenesis bear the α or β TCR, although 
γ or δ TCR+ cells are also enriched in atherosclerotic lesions. Expression of 
HSP 60 by intimal cells, caused, eg, by hemodynamic shear forces, may be 
responsible for recruitment of HSP-sensitized T cells, thus leading to the 
induction of an initiating inflammatory process in atherosclerosis. Other risk 
factors, such as high serum cholesterol levels, contribute to the final outcome 
of the disease. 
 
 





 A. Graham Pockley (2000 ) 57 demonstrated HSP 60 was present in all 
of the patients with Boderline Hypertension, Circulating HSP 70 was 
detectable in 36 of the 65 individuals with Boderline Hypertension and 37 of 
the 75 control subjects. Anti– HumHSP 60, anti– HumHSP 60, and anti–
MycHSP 65 antibodies were detected in all of the Boderline Hypertension 
samples analyzed and also he analysed the relationships Among HSP, Anti-
HSP antibodies,I/M Thickness, Blood Pressure Levels, and Metabolic 
Variables. There were significant associations between HSP 60 and Diastolic 
Blood Pressure and 24-hour systolic BP and there was no significant 
association between HSP  or HSP antibody levels and BP parameters when the 
Boderline Hypertension and Normotensive groups were analyzed separately. 
Amir Kol (2000 )34  He  hypothesised that HSP 60 activates 
mononuclear cells and macrophages through CD14 signaling. As a measure of 
cellular activation, he assessed the cellular production of IL-6, an important 
proinflammatory cytokine and mediator of the acute phase response HumHSP 
60 induced the synthesis of IL-6 by PBMC. HSP 60 induced IL-6 similarly to 
optimal concentrations of Escherichia coli LPS. Preincubation of PBMC with 
an anti-CD14 Ab blocked IL-6 production in response to either HSP 60 or 
Escherichia Coli LPS. The anti-CD14 Antibody did not inhibit this response 









Qingbo Xu et al (2000)78 demonstrated that markers of inflammation 
(C-reactive protein or soluble ICAM-1) and the presence of chronic infections 
are strongly associated with the development of atherosclerosis in the carotid 
arteries and also he demonstrated that the predictive significance of serum 
HSP 60 for atherosclerosis progression grows with laboratory and/or clinical 
evidence of chronic infection/inflammation. 
Pockley, A. Graham et al (2000)57 demonstrated that HSP 60, HSP 70 
and anti-HSP 60 antibody levels in hypertension were similar to those in 
normotensive controls, whereas anti-HSP 70 and anti-HSP 65 antibody levels 
were elevated HSP 60 levels and atherosclerosis were not associated. Anti-
HSP 70 and anti-HSP 65 antibody levels were both associated with 
hypertension, independently of age, smoking habits and blood lipids. 
Hannes Perschinka(2003)52 purified serum antibodies to Escherichia 
coli HSP 60 (GroEL), the 60-kD Chlamydial HSP, and HSP 65 of 
Mycobacterium tuberculosis by affinity chromatography from clinically 
healthy subjects with sonographically proven carotid atherosclerosis. 
Reactivity of the purified antibodies with overlapping HumHSP 60 peptides 
was measured, and 8 shared common epitopes, recognized by all anti-bacterial 
HSP 60/65 antibodies, were identified. Antisera specific for these cross-
reactive epitopes were produced by immunizing rabbits with peptides derived 
from HumHSP 60. By immunohistochemistry, the epitopes were found to be 
present in the arterial wall of young subjects during the earliest stages of the 
 
 





disease. Antibodies to microbial HSP 60/65 recognize specific epitopes on 
HumHSP 60. These cross-reactive epitopes were shown to serve as 
autoimmune targets in incipient atherosclerosis and might provide further 
insights into the mechanisms of early atherogenesis. 
Chung SW et al (2003)10 evaluated the recognition of Porphyromonas 
gingivalis HSP 60 and HumHSP 60 by immune sera in P. gingivalis-infected 
periodontitis and atherosclerosis patients. Mononuclear cells from atheroma 
lesions were stimulated with Porphyromonas gingivalis HSP and sera from 
periodontitis or atherosclerosis patients were subjected to Western 
immunoblotting to Porphyromonas gingivalis HSP or HumHSP , respectively. 
 Western immunoblot analysis demonstrated the dual reactivity of anti- 
Porphyromonas gingivalis antisera with Porphyromonas gingivalis HSP and 
HumHSP. We could also establish Porphyromonas gingivalis HSP - specific T 
cell lines from the atheroma lesions, a mixture of CD4+ and CD8+ cells 
producing the cytokines characteristic of both Th1 and Th2 subsets. He 
suggested  the modulating effect of Porphyromonas gingivalis HSP 60 in the 
immunopathogenesis of periodontitis and atherosclerosis. 
           J. I. Choi in ( 2004)9  Identified the T- and/or cross-reactive B-cell 
epitopes of Porphyromonas gingivalis and HumHSP 60 in atherosclerosis 
patients. Periodontitis patients with elevated IgG antibody responses to only 
Porphyromonas gingivalis were included in the study.T-cell epitopes of 
Porphyromonas gingivalis HSP 60 were identified with the use of previously 
 
 





established Porphyromonas gingivalis HSP-reactive T-cell lines. B-cell 
epitopes of P. Gingivalis HSP 60 and HumHSP 60 were identified by the use 
of patients' sera. Anti-Porphyromonas gingivalis , anti-Porphyromonas 
gingivalis HSP 60, or anti- HumHSP 60 ,IgG antibody titers were higher in the 
atherosclerosis patients compared with the healthy subjects. He concluded that 
Porphyromonas gingivalis HSP 60 might be involved in the immunoregulatory 
process of atherosclerosis, with  common T- and/or B-cell epitope specificities 
and  cross-reactivity with HumHSP 60 
          J. I. Choi (2004)8 evaluated the T-cell immune responses specific to 
Porphyromonas gingivalis HSP 60 in patients suffering from atherosclerosis. 
Anti- Porphyromonas gingivalis HSP 60 IgG antibody titers were elevated in 
all patients. Porphyromonas gingivalis HSP -specific T-cell lines from the 
atheroma lesions and the peripheral blood has been establised. The T-cell lines 
were a mixture of CD4+ and CD8+cells producing the cytokines characteristic 
of both Th1 and Th2 subsets.  He suggested that the T-cell immune response 
specific to Porphyromonas gingivalis HSP 60 may be involved in the 
immunopathologic process of atherosclerotic diseases. 
Yamazaki K (2004)79 Compared the cellular and humoral immune 
responses to HSP 60 in atherosclerosis patients and periodontitis patients and 
healthy subjects using human and Porphyromonas gingivalis HSP 60 (GroEL) 
as antigens. Antibody levels to both human and Porphyromonas gingivalis 
HSP 60s were the highest in atherosclerosis patients, followed by periodontitis 
 
 





patients and healthy subjects. Clonal analysis of the T cells clearly 
demonstrated the presence of not only HumHSP 60 - but also Porphyromonas 
gingivalis GroEL-reactive T-cell populations in the peripheral circulation of 
atherosclerosis patients. Furthermore, these HSP 60-reactive T cells seemed to 
be present in atherosclerotic lesions in some patients. These results suggest 
that T-cell clones with the same specificity may be involved in the 
pathogenesis of the different diseases. 
            Qingzhong Xiao, MD (2005)58 tested whether soluble HSP60 levels 
are associated with the progression of carotid arteriosclerosis, prospectively 
.The association of soluble HSP60 with early atherogenesis (5-year 
development and progression of nonstenotic carotid plaques) was investigated. 
The follow-up period was between 1995 and 2000 and, included 684 subjects. 
soluble HSP60 levels measured in 1995 and 2000 were highly correlated 
indicating consistency over a 5-year period. Circulating HSP60 levels were 
significantly correlated with anti-lipopolysaccharide and anti-HSP60 
antibodies. HSP60 levels were significantly associated with early 
atherogenesis, both in the entire population The risk of early atherogenesis 
was additionally amplified when high- soluble HSP60 and chronic infection 
were present together. He confirmed the association between high levels of 
soluble HSP60 and early carotid atherosclerosis. This possibly indicates an 
involvement of soluble HSP60 in activating proinflammatory processes 
associated with early vessel pathology. 
 
 





            Ford P et al (2006) 18 demonstrated presence of bacteria, including 
periodontopathogens in atherosclerotic plaques and suggested that cross-
reactivity of the immune response to bacterial GroEL with HumHSP 60 is a 
link between infections and atherosclerosis. 
Alireza Shamaei-Tousi et al (2007)63 measured the plasma levels of 
HSP10, HSP60 by immunoassay and related to other plasma measures of 
inflammation in periodontal patients and matched controls and also at 1 day 
and 6 months following periodontal or control therapy. Periodontal patients 
had significantly less circulating levels of HSP10 compared with the controls. 
In contrast, more periodontal patients had intermediate levels of HSP60. 
Treatment of the periodontitis caused an increase in plasma levels of HSP10. 
Treatment had no influence of HSP60 levels. Plasma HSP10 levels after 
therapy correlated with markers of periodontal clinical improvement. He 
concluded that circulating levels of molecular chaperones are influenced by 
local inflammation. The marked decrease of this circulating protein in active 
inflammation and its recovery post-treatment suggested that it may have a role 
in controlling periodontal inflammation. 
Salivary markers of periodontal inflammation:- 
  Saliva is a fluid that is readily available and contains locally-produced 
microbial and host response mediators, as well as systemic (serum) markers 
that may prove to be an aid in the diagnosis of periodontal disease and 
systemic disease. Salivary markers that have been studied as potential 
 
 





diagnostic tests for periodontal disease include proteins of host origin (i.e., 
enzymes, immunoglobulins), phenotypic markers, host cells, hormones 
(cortisol), bacteria and bacterial products, ions and volatile compounds. Saliva 
has been proposed as a noninvasive diagnostic fluid that could not only be 
used to help diagnose oral diseases, but as the body’s mirror that would also 
have application in the diagnosis of systemic conditions.  
The levels of salivary biomarkers, such as cytokines, could potentially 
be used as a surrogate to distinguish periodontally healthy individuals from 
subjects with periodontitis. Furthermore analysis of saliva may offer a cost-
effective approach to assessment of periodontal disease in large populations. 
Inspite of the recognized diagnostic potential of saliva, only a few reports have 
attempted to correlate the levels of cytokines in saliva with the periodontal 
condition of the subjects. 
Miller et al (2006)39  conducted a study to determine if salivary 
biomarkers specific for three aspects of periodontitis, namely inflammation, 
collagen degradation and bone turnover, correlated with clinical features of 
periodontal disease. He reported that the mean levels of IL 1 and MMP 8 in 
saliva were significantly higher in subjects with periodontitis than in 
periodontally healthy controls. 
Ruhl (2004)62 measured the levels of  IL 1, IL 6, IL 8, epidermal 
growth factor, nerve growth factor. He found that IL 1, IL 6, IL 8 were present 
 
 





in whole saliva at concentrations significantly higher than in major salivary 
gland secretions. 
Teles RP (2009)70 determined whether the levels of 10 different 
cytokines in saliva differed between a group of periodontally healthy 
individuals and a group of subjects with periodontitis. Correlations between 
the concentrations of these 10 cytokines and clinical parameters of periodontal 
disease were also examined. These cytokines are measured in whole saliva 
using a multiplexed bead immunoassay (Luminex). Mean salivary levels of 
granulocyte-macrophage colony-stimulating factor, interleukin-1beta, 
interleukin-2, interleukin-4, interleukin-5, interleukin-6, interleukin-8, 
interleukin-10, interferon-gamma and tumor necrosis factor-alpha could not 
discriminate between periodontal health and disease.  
Andrej Aurer (2005)6 measured the concentration of host 
inflammatory proteins: C-reactive protein (CRP), C3 and C4 complement 
components, alpha-2-macroglobulin and tumor-necrosis factor in unstimulated 
saliva of  periodontally health, edentulous persons,  patients with chronic 
periodontitis and in patients with aggressive periodontitis. TNF was below the 
level of detection in all samples except one. Edentulous persons and patients 
with chronic periodontitis had significantly reduced concentrations of CRP, 
C3 and alpha-2-macroglobulin. Edentulous persons and aggressive 
periodontitis patients had lower C4 concentrations. He concluded that 
edentulous persons and chronic periodontitis patients have reduced salivary 
 
 





concentrations of host inflammatory proteins and also suggested that a 
reduction in host responsiveness might play a role in the pathogenesis of 
chronic periodontitis. 
Tatjana Todorovic et al (2006)72 examined the activity of aspartate 
and alanine aminotransferase (AST, ALT), lactate dehydrogenase (LDH), 
creatine cinase (CK), alkaline and acidic phosphatase (ALP, ACP), gama 
glutamil transferase (GGT) in saliva from patients with periodontal disease 
before and after periodontal treatment and in saliva from healthy patients 
Patients with periodontal disease were under conventional periodontal 
treatment. There was  statistically significant increase of activity of aspartate 
and alanine aminotransferase (AST, ALT), lactate dehydrogenase (LDH), 
creatine cinase (CK), alkaline and acidic phosphatase (ALP, ACP), gama 
glutamil transferase (GGT) in saliva from patients with periodontal disease in 
relation to control group and also a positive correlation between the activity of 
examined salivary enzymes and value of the gingival index. After 
conventional periodontal therapy the activity of all salivary enzymes was 
significantly decreased. He concluded that activity of these enzymes in saliva, 
as biochemical markers for periodontal tissue damage, may be useful in 
diagnosis, prognosis and evaluation of therapy effects in periodontal disease. 
Balwant Rai et al (2008)59  estimated salivary TNF α levels in 
periodontitis and healthy normal. Significantly higher levels Salivary TNF α 
was observed in periodontitis patients as compared to controls (p<0.001). He 
 
 





concluded that Saliva provides an ideal medium for the detection of 
proinflammatory markers of the oral cavity. Salivary TNF α analysis may be a 
useful diagnostic tool and a potential prognostic marker in periodontal disease. 
Patricia Yen Bee Ng (2007)50 evaluated the association between 
radiographic evidence of alveolar bone loss and the concentration of host-
derived bone resorptive factors (interleukin-1 beta, TNF α, interleukin-6, 
prostaglandin-E2), and markers of bone turnover [pyridinoline crosslinked 
carboxyterminal telopeptide of type I collagen (ICTP), osteocalcin, 
osteonectin] in stimulated human whole saliva collected from untreated dental 
patients. Alveolar bone loss scores for each patient were derived from 
radiographic examination. Variables positively associated with increased bone 
loss score were: age, current smoking, use of bisphosphonate drugs, and 
salivary interleukin-1beta levels above the median. Salivary osteonectin levels 
above the median were associated with a decreased bone loss score. 
Additional in vitro studies were carried out to determine the fate of 
interleukin-1beta, interleukin-6 and TNF-α added to whole and parotid saliva. 
All cytokines added to saliva were detected in significantly lower 
concentrations than when added to buffer alone. He concluded that detection 
of biomarkers by conventional immunoassays may underestimate the actual 
quantity of molecules in saliva. 
Diagnostic methods used in clinical practice today lack the ability to 
detect the onset of inflammation and to identify those patients who are 
 
 





susceptibity to future disease progression. oral fluid based  point of care(POC) 
diagnostics are commonly used in medicine and, more recently, arte breing 
adapted for the potential “ chair side “ determination of oral diseases.the latest 
clinical applications use new” lab-on-a-chip”(LOC) technologies as rapid POC 
diagnostic test for systemic infectious diseases and periodontal disease. 26 The 
development of rapid Point of Care chair side diagnostics has the potential for 
the early detection of periodontal infection and progression to identify the 
incipient disease.   
Amy e. Herr, Anson v. hatch,  William v. Giannobile (2007)26 
developed a portable microfluidic device for detection of potential biomarkers 
of periodontal disease in saliva. The device performs rapid microfluidic chip-
based immunoassays (<3–10 min) with low sample volume requirements (10 
μL) and appreciable sensitivity. This method facilitates hands-free saliva 
analysis by integrating sample pretreatment (filtering, enrichment, mixing) 
with electrophoretic immunoassays to quickly measure analyte concentrations 
in minimally pre treated saliva samples. The microfluidic chip has been 
integrated with miniaturized electronics, optical elements, such as diode lasers, 
fluid-handling components, and data acquisition software to develop a 
portable, self-contained device. The device and methods are being tested by 
detecting potential biomarkers in saliva samples from patients diagnosed with 
periodontal disease. The microchip-based analysis can readily be extended to 
detection of biomarkers of other diseases, both oral and systemic, in saliva and  
 
 






 Molecular chaperones were considered to be intracellular, but there is 
increasing evidence demonstrating their cytoprotective and immune modulator 
properties outside the cell, exerting cytokine-like effects and influencing 
immune recognition. There is scant evidence regarding HSP 60 in saliva. 
However the major extracellular chaperone HSP 70 was found in saliva, 
indicating a possible effect of HSP 70 on mucosal surfaces.  HSP 70 has been 
found to be present in human blood sera. Cpn10 and Cpn60 are present in 
pancreatic juice, but HSP 70 is not. These observations raise the possibility 
that molecular chaperones may be present in other secretory fluids, such as 
human saliva. 
 Fabian  TK et al (2007)15 summarized the immune-modulatory role of 
the 70-kDa stress protein family, with special attention on the potential impact 
of salivary HSP 70 on oral defense mechanisms. Three major facets of HSP 
70-induced immune activation are : 1) the appearance of HSP 70 on the 
surface of certain tumor cells or virally infected cells, leading to their 
phagocytosis and subsequent lysis; 2) the role of extracellular uncomplexed 
HSP 70 as a danger signal, leading to the secretion of proinflammatory 
cytokines from antigen-presenting cells and T lymphocytes and of nitric oxide 
from macrophages as well as to complement activation; 3) receptor-mediated 
uptake of peptide-loaded HSP 70 to antigen-presenting cells and cross-
presentation of the HSP 70-peptide complex as an antigen to cytotoxic T cells 
 
 





and natural killer lymphocytes. The immune-activating effect of salivary HSP 
70 may also be highly important in oral defense, especially in areas where 
molecular and cellular participants of the immune response appear on the 
surface of the oral cavity (i.e. several lesions of the mucosa and the 
periodontal tissues). 
Fabian TK (2003)16  Human whole saliva was collected from six 
participants under resting conditions and secretory stimulation. The samples 
were precleared by centrifugation and sterile filtered. Salivary volume, protein 
concentration and amylase activity were determined. For detection of HSP 70 
saliva proteins were separated on a 12.5% SDS polyacrylamide gel. Semi-dry 
Western blot analysis was used with a primary antibody against the inducible 
form of HSP 70. There was a significant decrease of HSP 70, and a non-
significant decrease of total protein concentration during stimulation, whereas 
the activity of salivary amylase increased significantly. Stimulation 
significantly increased the HSP 70, total protein and amylase outputs as well 
as the amylase/protein ratio, and decreased the HSP 70/amylase and HSP 
70/protein ratios. He concluded that HSP 70 is secreted to saliva, but unlike 
amylase is not transported by the exocytotic secretory mechanisms of acinar 
cells. Passive transport mechanisms of HSP 70 from blood serum or from 
salivary gland cells may be major routes of salivary HSP 70 secretion. 
Fejerdy L (2004)17  investigated whether repeated, short-term  heat 
and mechanical stimulation of the salivary glands can specifically modify the 
 
 





salivary HSP 70 concentration in the human whole saliva. Both kind of 
stimulation increased the secretory rate significantly,  during stimulation, but 
it decreased to control level in resting phases. HSP 70 concentration 
increased after the first stimulation in the case of mechanical stress and after 
the second stimulation in the case of heat stimulation. In contrast, a 
significant  confluent increase of total protein concentration and amylase 
activity occurred after the first stimulation in the case of heat stimulation and 








MATERIALS AND METHODS 
Study Population 
45 patients (21 males and 24 females) who attended the out patient 
Department of periodontology, Ragas Dental College and Hospitals, Chennai 
were enrolled in the study. Patients were divided into two groups based on 
their periodontal health status. Informed consent was obtained from all the 
patients. The patients were informed that this research work was in no way 
directly related to the therapy or cure of the disease. The study was undertaken 
following approval from the institutional review board. 
Selection criteria 
Group A: Healthy Gingiva - Patients exhibiting no signs of periodontal 
disease, determined by the absence of clinical attachment loss, absence of 
bleeding on probing. PPD <3mm. 
Group B: Periodontitis - Patients with teeth exhibiting PPD ≥ 5 mm and            
CAL  ≥ 3mm and radiographic evidence of bone loss in atleast 6 teeth.5 
Exclusion criteria 
• Patients with history of periodontal therapy or antibiotic therapy in the 








• Patients with history of systemic diseases that may affect the 
periodontal status 
• Pregnancy and Lactation 
• Smokers 
• Evidence of any other active oral infections eg: pulpal pathology. 
Clinical evaluation:-  
 Clinical evaluation was done using mouth mirror and William’s 
periodontal probe. The probing depth, clinical attachment loss, bleeding on 
probing was evaluated. From the above measurements, biofilm gingival 
interface index (BGI) was calculated as follows, 
BGI-Healthy (BGI-H)          -  probing depth ≤ 3mm and < 10 %   
     bleeding on probing 
BGI- Gingivitis (BGI-G)        -       probing depth ≤ 3mm and ≥ 10 %   
     bleeding on probing 
BGI- Deep lesion / low bleeding -   one or more sites with probing  
(BGI-DL/LB)     depth ≥4mm   and < 10 %  bleeding on 
     probing 
 
BGI- Deep lesion / moderate bleeding -  one or more sites with probing depth 
(BGI-DL/MB)     ≥4mm and 10 to 50 %  bleeding on  
     probing 
BGI- Deep lesion / severe  bleeding - one or more sites with probing   
(BGI-DL/SB)     depth ≥4mm and ≥ 50 %  bleeding on 








Sample collection  
3 ml of Peripheral blood drawn from patients using venepuncture from 
the antecubital fossa to be used for ELISA analysis as well as for total and 
differential white blood cell count estimations. 
Peripheral blood was drawn prior to onset of Phase I periodontal 
therapy in periodontitis patients. All patients underwent a complete physical 
examination and hematological investigation in Ragas General Hospital to rule 
out systemic diseases.  
Saliva collection:- 
Salivary collection is done according to the technique by Navazesh et 
al (2008)43. The patients were advised to refrain from intake of any food or 
beverage (water exempted) one hour before the test session. The subjects were 
advised to rinse his or her mouth several times with distilled water and then to 
relax for five minutes. The patient is asked to lean the head forward over the 
container with the mouth slightly open and allow the saliva to drain into the 
container with the eyes open. The time lasted for saliva collection is five 
minutes, the saliva is collected in a sterile disposable plastic container and the 









1. Disposable needle and syringe 
2.  Vaccutainers 
3.  Test Tubes 
4. Centrifuge Tubes 
5. Micropipettes 
6. Micropipette tips 
7. Pasteur pipette 
8. Laboratory Centrifuge 
9. Refrigerator 
    10. Autoclavable Scott Duran bottles     
    11. Autoclavable containers for saliva collection 
    12. Haemocytometer  
    13. Electronic balance   
    14. Light Microscope                                                       
    15.Ice pack (for transfer) 
Reagents Required:- 
1. Phosphate Buffered Saline (freshly prepared) 
           Formulation:  








- Potassium Dihydrogen Phosphate (KH2PO4) : 200mg 
- Disodium Hydrogen Phosphate ( Na2HPO4 ) :2.9g 
- Potassium Chloride(KCl) : 500 mg 
- Distilled Water(H2O) : 1 litre 
2. Histopaque- 1077 – For Isolation of Mononuclear Cells 
Solution of polysucrose and sodium diatrizoate, adjusted to a density of 
1.077 g/ml.  
3. Distilled water 
4. HSP 60 ELISA KIT(ASSAY DESIGNS) 
Serum sample preparation:- 
3ml of blood was drawn by vene puncture in anticubital fossa. 2ml of 
blood was allowed to clot at room temperature for 30 mins & centrifuged at 
3000 rpm for 10 mins. Serum was then divided into 2 aliqouts and transferred 
to labelled poly propylene tubes and stored at -70o c and used for further 
analysis.   
Cell lysate preparation:-                                         
 Out of 3 ml; 1 ml of the Sample was collected into vaccutainers 








buffer saline(PBS).this mixture was carefully layered in a centrifuge tube 
containing 3ml of Histopaque  -1077 (Sigma Aldrich) centrifugation at 3000 
rpm for 30 mins. The buffy coat layer containing lymphocytes and 
mononuclear cells are separated and washed twice with 10ml PBS at 2000 rpm 
for 10 mins. 1ml 1x extraction reagent was added per 1ml of blood. The 
extract was incubated for 30 mins on ice. The extract was centrifuged in 
polypropylene microcentrifuge tube at 21000 rpm for mins in a refrigerated 
microfuge (Remi) at 40 c. The supernatants were obtained and stored at -700c 
and used for further  analysis. 
Enzyme linked immunoassay for HSP 60:- 
   Serum, cell lysate and saliva samples were diluted in sample Dilutent(1:50) 
•   Six polypropylene tube each with one of the following  standard 
values was prepared.100mg/ml,  50mg/ml.,  25mg/ml,  12.5mg/ml,  
6.25mg/ml, 3.125mg/ml. 
•  To the 96 pre coated   micro litre  wells ,100 micro ml of prepared 
HSP 60 standard (Tube #1 to Tube#2) ,sample and zero standard 
(0mg/ml) was added and incubated at room temperature for 60 mins. 
•  Liquid from all the wells were aspirated  and washed with 
300microliter of 1x wash buffer for 6 times using automatic washer. 
•  After the 6th wash, 100 micro litre of previously diluted Anti HSP 








room temperature for 60 mins .the plates were washed with wash 
buffer as described previously. 
•  100 micro litre of previously diluted HRP (Horse radish peroxidise) 
conjugate was added to each well excepting the blank, and incubated 
at room temperature for 30 mins .plates were washed with wash 
buffer for 6 times. 
•  100 micro litre of TMB( Tetramethylbenzidine) substrate was added 
to every well colour developed was visible within 1minute of addition 
to the wells. 
•  Finally 100 micro litre of stop solution 2 was added to the wells. 
•  Microplate reader was set according to the manufacturers instruction 
at a wavelength of 450 mm and absorbance was measured. 
Measurement of  High Sensitivity C- Reactive Protein (hs-CRP):- 
Measurement of hs-CRP was performed using a  immunoturbidimetric 
assay performed on a Randox Daytoner analyzer  ( Randex Laboratories, 
Crumlin Co., Autrium, UK). The assay range was 0.1 to 20 mg/l and detection 









 The circulatory HSP 60  levels were obtained by adding cell lysate 
HSP levels and serum HSP 60 levels. The circulatory and salivary levels of 
HSP 60 in periodontal health and disease was compared by calculating the 
mean and standard deviation for each group. Student T test was used for 
statistical analysis and P value was calculated. Correlation coefficient of 
serum, saliva and cell lysates of HSP 60 in periodontal health and disease was 
analysed using Pearson’s correlation. P< 0.05 was considered to be 
statistically significant at the 5% level. 






45 patients (21 males and 24 females) who attended the out patient 
Department of periodontology, Ragas Dental College and Hospitals, Chennai 
were enrolled in the study. Patients were divided into two groups based on 
their periodontal health status. Informed consent was obtained from all the 
patients. The patients were informed that this research work was in no way 
directly related to the therapy or cure of the disease. The study was undertaken 
following approval from the institutional review board. 
Selection criteria 
Group A: Healthy Gingiva - Patients exhibiting no signs of periodontal 
disease, determined by the absence of clinical attachment loss, absence of 
bleeding on probing. PPD <3mm. 
Group B: Periodontitis - Patients with teeth exhibiting PPD  5 mm and            
CAL   3mm and radiographic evidence of bone loss in atleast 6 teeth.5
Exclusion criteria 
x Patients with history of periodontal therapy or antibiotic therapy in the 
past 6 months  




x Patients with history of systemic diseases that may affect the 
periodontal status 
x Pregnancy and Lactation 
x Smokers 
x Evidence of any other active oral infections eg: pulpal pathology. 
Clinical evaluation:-  
Clinical evaluation was done using mouth mirror and William’s 
periodontal probe. The probing depth, clinical attachment loss, bleeding on 
probing was evaluated. From the above measurements, biofilm gingival 
interface index (BGI) was calculated as follows, 
BGI-Healthy (BGI-H)          -  probing depth  3mm and < 10 %   
     bleeding on probing 
BGI- Gingivitis (BGI-G)        -       probing depth  3mm and  10 %
     bleeding on probing 
BGI- Deep lesion / low bleeding -   one or more sites with probing  
(BGI-DL/LB)     depth 4mm   and < 10 %  bleeding on 
     probing 
BGI- Deep lesion / moderate bleeding -  one or more sites with probing depth 
(BGI-DL/MB)     4mm and 10 to 50 %  bleeding on  
     probing 
BGI- Deep lesion / severe  bleeding - one or more sites with probing   
(BGI-DL/SB)     depth 4mm and  50 %  bleeding on 
     probing




Sample collection  
3 ml of Peripheral blood drawn from patients using venepuncture from 
the antecubital fossa to be used for ELISA analysis as well as for total and 
differential white blood cell count estimations.
Peripheral blood was drawn prior to onset of Phase I periodontal 
therapy in periodontitis patients. All patients underwent a complete physical 
examination and hematological investigation in Ragas General Hospital to rule 
out systemic diseases.  
Saliva collection:-
Salivary collection is done according to the technique by Navazesh et 
al (2008)43. The patients were advised to refrain from intake of any food or 
beverage (water exempted) one hour before the test session. The subjects were 
advised to rinse his or her mouth several times with distilled water and then to 
relax for five minutes. The patient is asked to lean the head forward over the 
container with the mouth slightly open and allow the saliva to drain into the 
container with the eyes open. The time lasted for saliva collection is five 
minutes, the saliva is collected in a sterile disposable plastic container and the 
samples were stored at -70o C and used for further analysis. 





1. Disposable needle and syringe 
2.  Vaccutainers 
3.  Test Tubes 
4. Centrifuge Tubes 
5. Micropipettes 
6. Micropipette tips 
7. Pasteur pipette 
8. Laboratory Centrifuge 
9. Refrigerator 
    10. Autoclavable Scott Duran bottles     
    11. Autoclavable containers for saliva collection 
    12. Haemocytometer  
    13. Electronic balance   
    14. Light Microscope                                                       
    15.Ice pack (for transfer) 
Reagents Required:- 
1. Phosphate Buffered Saline (freshly prepared) 
           Formulation:  
- Sodium chloride (NaCl) : 8g 




- Potassium Dihydrogen Phosphate (KH2PO4) : 200mg 
- Disodium Hydrogen Phosphate ( Na2HPO4 ) :2.9g 
- Potassium Chloride(KCl) : 500 mg 
- Distilled Water(H2O) : 1 litre 
2. Histopaque- 1077 – For Isolation of Mononuclear Cells 
Solution of polysucrose and sodium diatrizoate, adjusted to a density of 
1.077 g/ml.  
3. Distilled water 
4. HSP 60 ELISA KIT(ASSAY DESIGNS)
Serum sample preparation:- 
3ml of blood was drawn by vene puncture in anticubital fossa. 2ml of 
blood was allowed to clot at room temperature for 30 mins & centrifuged at 
3000 rpm for 10 mins. Serum was then divided into 2 aliqouts and transferred 
to labelled poly propylene tubes and stored at -70o c and used for further 
analysis. 
Cell lysate preparation:-                                         
 Out of 3 ml; 1 ml of the Sample was collected into vaccutainers 
containing anticoagulant (EDTA). 1ml of blood was added to2ml of phosphate 




buffer saline(PBS).this mixture was carefully layered in a centrifuge tube 
containing 3ml of Histopaque  -1077 (Sigma Aldrich) centrifugation at 3000 
rpm for 30 mins. The buffy coat layer containing lymphocytes and 
mononuclear cells are separated and washed twice with 10ml PBS at 2000 rpm 
for 10 mins. 1ml 1x extraction reagent was added per 1ml of blood. The 
extract was incubated for 30 mins on ice. The extract was centrifuged in 
polypropylene microcentrifuge tube at 21000 rpm for mins in a refrigerated 
microfuge (Remi) at 40 c. The supernatants were obtained and stored at -700c
and used for further  analysis. 
Enzyme linked immunoassay for HSP 60:- 
   Serum, cell lysate and saliva samples were diluted in sample Dilutent(1:50) 
x   Six polypropylene tube each with one of the following  standard 
values was prepared.100mg/ml,  50mg/ml.,  25mg/ml,  12.5mg/ml,  
6.25mg/ml, 3.125mg/ml. 
x  To the 96 pre coated   micro litre  wells ,100 micro ml of prepared 
HSP 60 standard (Tube #1 to Tube#2) ,sample and zero standard 
(0mg/ml) was added and incubated at room temperature for 60 mins. 
x  Liquid from all the wells were aspirated  and washed with 
300microliter of 1x wash buffer for 6 times using automatic washer. 
x  After the 6th wash, 100 micro litre of previously diluted Anti HSP 
60(Goat polyclonal antibody) was added to each well and incubated at 




room temperature for 60 mins .the plates were washed with wash 
buffer as described previously. 
x  100 micro litre of previously diluted HRP (Horse radish peroxidise) 
conjugate was added to each well excepting the blank, and incubated 
at room temperature for 30 mins .plates were washed with wash 
buffer for 6 times. 
x  100 micro litre of TMB( Tetramethylbenzidine) substrate was added 
to every well colour developed was visible within 1minute of addition 
to the wells. 
x  Finally 100 micro litre of stop solution 2 was added to the wells. 
x  Microplate reader was set according to the manufacturers instruction 
at a wavelength of 450 mm and absorbance was measured. 
Measurement of  High Sensitivity C- Reactive Protein (hs-CRP):- 
Measurement of hs-CRP was performed using a  immunoturbidimetric 
assay performed on a Randox Daytoner analyzer  ( Randex Laboratories, 
Crumlin Co., Autrium, UK). The assay range was 0.1 to 20 mg/l and detection 
limit was 0.03 mg/l. 





 The circulatory HSP 60  levels were obtained by adding cell lysate 
HSP levels and serum HSP 60 levels. The circulatory and salivary levels of 
HSP 60 in periodontal health and disease was compared by calculating the 
mean and standard deviation for each group. Student T test was used for 
statistical analysis and P value was calculated. Correlation coefficient of 
serum, saliva and cell lysates of HSP 60 in periodontal health and disease was 
analysed using Pearson’s correlation. P< 0.05 was considered to be 
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EVALUATION OF CIRCULATORY AND SALIVARY  
RAGAS DENTAL COLLEGE AND HOSPITAL, CHENNAI. 
DEPT OF PERIODONTICS 
PATIENT PROFORMA 
1. NAME : 
2. AGE/SEX  : 
3. OCCUPATION : 
4. ADDRESS : 
5. PHONE : 
6. CHIEF COMPLAINT : 
7. PAST DENTAL HISTORY : 
8. MEDICAL HISTORY : 
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1. Total Count: 
2. Differential Count: 
3. Bleeding Time: 
4. Clotting Time: 
5. Haemoglobin: 










           I have been explained about the nature and purpose of the study 
in which I have been asked to participate. I understand that, I am free to with 
draw my consent and discontinue at any Time without prejudice to me or 
effect on my treatment. 
                     I have been given the opportunity to ask questions about the 
procedure. I have also Given consent for photographs, blood and saliva 
samples to be taken for the study purpose. I have fully agreed to participate in 
this study. 
                      I hereby give my consent to be included in “EVALUATION 
OF CIRCULATORY AND SALIVARY LEVELS OF HEAT SHOCK 
PROTEIN 60 IN PERIODONTAL  HEALTH AND DISEASE”  
 
Station: 
Date:   
              Signature of the patient: 
 












 The present study assessed the circulatory and salivary levels of HSP 
60 in patients with periodontal health and disease by sandwich ELISA method. 
 45 peripheral blood samples and saliva samples were collected from 
the 2 groups. Group A or group B ( 22 health and 23 disease). The blood 
samples were processed. Serum and cell lysates were prepared to detect HSP 
60 between the two groups 
 Absorbance was measured at 450nm wavelength in terms of ng/dl, and 
the results were obtained. 
HS CRP (table 1) 
 The mean hs CRP level in periodontal disease was 2.25 ng/dl whereas 
the mean hs CRP in periodontal health was 1.16 ng/dl. There was a significant 
increase in the periodontal disease when compared to health at p < 0.05 
(0.024). 
Circulatory HSP 60 (table 2) 
The mean circulatory HSP 60  levels were obtained by adding the 
mean cell lysate HSP levels and the mean serum HSP 60 levels. The mean 
circulatory HSP 60 level ( total serum & cell lysate)  in periodontal disease 










There was a significant increase in the periodontal disease when compared to 
health at p <0.05 (0.038) 
When the circulating HSP60 levels were examined individually as cell 
lysate and serum levels, the results obtained were as follows: 
HSP 60 Cell lysates (table 3) 
The mean cell lysate level of HSP 60 in periodontal disease was 80.89 
ng/dl whereas the mean cell lysate level of HSP 60 in periodontal health was 
53.54 ng/dl. There was a significant increase in the periodontal disease when 
compared to health at p < 0.05 (0.044) 
HSP 60 Serum (table 4) 
The mean serum HSP 60 level in periodontal disease was 20.19 ng/dl 
whereas the mean serum HSP 60 level in periodontal health was 15.68 ng/dl. 
There was no significant increase in the periodontal disease when compared to 
health at p>0.05(0.488) 
Correlation between circulatory HSP 60 in hs CRP in periodontal disease 
( table: 6) 
 There was a statistically significant correlation between circulatory 










HSP 60 Saliva (table 4) 
The mean salivary level of HSP 60 in periodontal disease was 30.15 
ng/dl whereas the mean salivary level of HSP 60 in periodontal health was 
26.05 ng/dl. There was  no significant increase in the periodontal disease when 
compared to  health at p>0.05(0.628) 
Correlation coefficient for HSP 60 levels in serum, cell lysates and saliva 
of periodontally healthy patients ( table: 5) 
 There was no statistically significant correlation between the 
circulating HSP 60, salivary HSP 60 and hs CRP. Even when examined 
individually, there was no significant correlation between either serum HSP 60 
or cell lysate HSP 60 and salivary HSP 60.  
Correlation between  salivary HSP 60 and circulatory HSP 60 and hs 
CRP in periodontal disease ( table: 6) 
 There was no significant correlation between salivary HSP 60 and 
circulating HSP 60 (either total or individual). There was also no significant 







Table 1  
hs CRP  levels in serum 





Health 22 1.16 0.033 0.024* 
Disease 23 2.25 0.29 
 
Table 2 
Total circulatory HSP 60 levels in health and disease. 





Health 22 59.05 35.20 0.038* 








HSP 60 levels in cell lysates 





Health 22 53.54 30.52 0.044* 
Disease 23 80.89 49.46 
 
Table  4 
HSP 60 levels in saliva and serum 
Group Mean Standard 
deviation 
P value 
Serum Health 15.68 10.02 0.488 
Disease 20.19 16.57 
Saliva Health 26.04 14.36 0.628 





Table  5 
Pearson’s correlation for total circulatory levels and hsCRP & 











Serum Cell lysate 70% 0.995 
Cell lysate Saliva 10% 0.419 
Saliva Serum 3% 0.558 
 
Table  6 
Pearson’s correlation for total circulatory levels and hsCRP & 












Serum Cell lysate 15% 0.967 
Cell lysate Saliva 11% 0.280 




Figure 1  












Figure 2  














Figure 3  















Figure 4  
Comparision of salivary HSP 60 in periodontal health and disease 





















Although periodontopathic bacteria are the primary etiological agents 
in periodontal disease, the ultimate determinant of disease progression and 
clinical outcome is the host's immune response. The immune response is 
typically activated through exposure to bacterial antigens with specific 
Pathogen associated molecular patterns(PAMPs) such as LPS , fimbriae, & 
Outer membranous protein, etc.23 In addition to these PAMPs, self antigens 
have also been reported to be involved in host inflammatory / immune 
response.75,81 
Among the most studied self antigen in periodontal disease is the heat 
shock protein, especially HSP 60. HSP 60 has been reported to be significantly 
elevated in gingival tissues affected by periodontal disease, but, there is no 
conclusive evidence linking it to disease activity. HSP’s are typically regarded 
as intracellular proteins but free serum HSP 60 has been reportedly identified 
and  linked to systemic inflammation and cardiovascular disease.10,30,57,33  The 
source of this free circulating HSP 60 remains a controversy. This study was 
undertaken to investigate if periodontal disease could contribute to the 
circulating HSP 60 levels in a manner similar to that of circulating 








Peripheral blood was collected from the antecubital fossa, and 
lymphocytes were separated from the peripheral blood using Histopaque-
1077. Cell lysates were prepared using the extraction  reagent provided in the 
heat shock protein 60 ELISA kit  following standard protocol, as reported by 
other studies.3,60,49, 
Saliva was collected by the method, reported by Navazesh et al 
(2008)43. Care was taken to ensure that, saliva was collected between 9-11 AM 
to avoid variation due to circadian periodicity that has been shown to affect 
salivary analytes.71 
The ELISA method was used to evaluate HSP 60 in preference to 
immunoblotting as it is versatile, accurate, reproducible, and economical. 
Previous studies done by Tabeta K et al (2001)68, Watanabe S et al (2003)76 
and  Handley HH et al (1995) 24 provide evidence that supports the use of this 
method.  
In our study, patients were divided only into health and periodontitis 
groups, a gingivitis group was not included. Previous studies have reported 
that gingivitis occurs as a non specific local inflammatory response to plaque 
& does not seem to produce a significant systemic inflammatory response.80 
Patients in the periodontitis groups were not sub classified into mild, 








1) Previous results on the systemic inflammatory effects of periodontal 
disease have been inconclusive in detecting significant differences 
between mild, moderate and severe periodontitis. A paucity in the 
number of well controlled, prospective, longitudinal trials could be one 
reason for this lack of evidence. 
2) We have used the BGI index in this study for clinical categorisation of 
chronic periodontitis. 
The BGI proposed by Barros and Offenbacher, has been suggested to 
be dynamic and therefore a sensitive predictor of the systemic effects of 
periodontal disease. As the events occurring at the biofilm gingival interface 
demonstrably influence the inflammatory course, this index is thought to be a 
more reliable predictor of systemic inflammation.  Only the BGI Deep lesion 
(BGI-DL) category was included due to practical difficulties in including an 
adequate sample of all groups for investigative procedures. Further, previous 
studies have reported that, systemic effects of periodontal disease were 
associated most significantly with the BGI-DL .48 
The result of our study indicate that, there was a significant increase in 
hs CRP levels in periodontal disease when compared to health . These results 
are in consistent with the reports of Renvert, Nakajima et al. The advantage of 
using hs CRP over conventional CRP is that it is more sensitive and there by 








seem to add on to the existing body of literature that suggests that periodontal 
disease is capable of evoking a low grade chronic systemic inflammation. 
There was no significant difference between the hs CRP levels and BGI MB 
and SB groups but the sample size of individual subgroup was too small for 
meaningful analysis. None of the patients included in our study belonged to 
the BGI-DL/LB category. A larger sample size could have provided predictive 
information about the reliability of the BGI index in populations with poor 
oral hygiene where gingival bleeding is very common. While these results 
cannot be compared directly, Barros and co workers have reported somewhat 
similar results in their study relating to HbA1c levels in diabetes mellitus 
samples. 
The results of our study indicate that there was a significant increase in 
circulating HSP 60 in periodontal disease when compared to health. These 
results are in conformity with previous studies of  Ukei et al ( 2002)73, 
Yamazaki et al (2002)80.  
In order to further clarify its role in pathogenesis, cell lysate and serum 
HSP 60 levels were examined individually. The cell lysate HSP 60 levels were 
consistently higher when compared to serum in both health and disease 
groups. These results suggest that the primary source of circulatory HSP 60 








In periodontal disease, there was a significant elevation in cell lysate 
HSP 60 levels, while the serum levels showed no significant difference when 
compared to health. Although periodontal disease has been reported to result 
in a systemic spill over of proinflammatory cytokines such as IL-1, IL-6, TNF 
α etc,47 other host derived products have not been extensively documented. 
The fact that periodontal disease was associated with an upregulation of cell 
lysate HSP 60 & not free serum HSP 60 suggests that this has not resulted 
from a mere systemic spill over. Whether this lymphocyte reaction was in 
response to HSP 60 1) of Porphyromonas gingivalis in gingival tissues or 2) 
Porphyromonas gingivalis in circulation or 3) in human fibroblasts, could not 
be determined. Previous evidence suggests the plausibility of any or all of the 
above. 
Systemic cellular responses to locally generated antigens have been 
previously described in the form of hyper responsive monocytes.32 The ability 
of Porphyromonas gingivalis to enter circulation and colonize tissues other 
than gingiva has been well documented.84 The structural homology between 
HSP 60 of Porphyromonas gingivalis with an epitope MQFDRGYISP and 
HumHSP 60 with an epitope MKFDRGYISP makes the third possibility 
distinctly plausible. 69 Further strength for this hypothesis may be gained from 
the generation of HSP 60 specific γ δ T cells that are normally involved in 








Similar to the results obtained with hs CRP, there was no correlation 
between circulatory HSP 60 levels, and BGI (MB and SB). The reason for this 
lack of association is not immediately apparent but the small sample size of 
the subgroup could have influenced the results. It may also be speculated that 
these self antigens are involved in early phases of established periodontitis and 
their further effects could probably be related to activation of the immune 
response. 
Regardless of the pathogenic mechanism involved in the HSP 60 
upregulation in periodontal disease; it is significant that it correlates positively 
with the systemic inflammatory status as indicated by hs CRP. The 
mechanisms through which HSP 60 could induce systemic inflammation have 
been well documented. In addition to activating Natural Killer Cells and γ δ T 
cells, 10 ; these proteins can result in increase of proinflammatory cytokines 
like TNF α.73 Both HSP 60 and hs CRP have been shown to be independently 
associated with cardiovascular disease.10,30,47,57,33 Therefore, upregulation of 
both circulating HSP 60 and hs CRP in periodontal disease could have 
important implications. 
 The association between periodontal disease and cardiovascular 
disease has gained enormous attention in recent years. Several investigators 
have found a strong association between the two diseases to the extent that a 








the periodontologists has addressed this issue.19 A number of pathogenic 
mechanisms have been suggested through which periodontal disease may 
affect cardiovascular disease.10,30,57,33 
Our study indicates that HSP 60 could be considered another potential 
candidate through which periodontal disease influences the systemic 
inflammatory state and thereby cardiovascular disease. The role of 
inflammation in the development of atheromatous plaques is now well 
established.79 
There has been a resurgent interest in salivary diagnostics in the last 
few years. Recent evidence demonstrated its ability to predict not only local 
inflammatory conditions such as chronic periodontal disease but also systemic 
conditions such as Cardiovascular disease, Breast cancer etc.1  Our results 
suggests that salivary HSP 60 levels exhibited no significant difference 
between periodontal health and disease. There is scant previous literature with 
which we can compare these levels. Previous studies on HSP are related to 
HSP 70 levels and have focused largely on salivary gland pathology. Saliva 
has been reported to be a second hand marker of periodontal disease as most 
of its constituents have gained entry from GCF.35 The lack of association 









The role of HSP 60 in the etiopathogenesis of periodontitis may be 
described as follows: 
Molecular mimicry with the HSP 60 of Porphyromonas gingivalis 
results in T cell activation against both the exogenous antigen as well the 
gingival fibroblasts. This leads to generation of T cell lines that may be 
destructive to the host tissue and result in excessive production of 
proinflammatory cytokines such as TNF α.73 
In other words; the pathogenic responses are restricted to immune 
complex activation against intracellular antigens (HSP 60 - either 
Porphyromonas gingivalis or gingival fibroblast) that are confined to the 
gingival tissue. Consequently; there is only a minimal presence of these 
proteins in inflammatory exudates and therefore, saliva. We hypothesize that 
due to these reasons; the salivary HSP 60 levels do not reflect periodontal 
disease activity. 
Salivary HSP 60 did not correlate with the circulating HSP 60 levels or hs 
CRP. The cell lysate HSP 60 levels indicate that the predominant systemic 
response to HSP 60 is cellular in nature. As saliva is generally thought to be 
reflective of the plasma or serum constituents; there was no significant 
correlation between salivary and circulating HSP 60. Consequently, it did not 
correlate with hs CRP either. This data must not be interpreted to mean that 








only that salivary HSP 60 is a poor marker of both periodontal disease and its 
systemic inflammatory response.   
There are several limitations in this study including: 
1. A small sample size which may have affected the statistical 
analysis. 
2. Its cross sectional nature;  longitudinal studies are better suited to 
study the episodic nature of periodontal disease & its biomarkers. 
3. Immunolocalization of HSP 60 in gingival tissues could have 
perhaps given a more complete picture. 
Within the limitations of this study; the significant association between 
periodontal disease, circulating HSP 60 and hs CRP indicates a strong 
possibility of the involvement of these self antigens in systemic inflammation. 
These results certainly warrant a more detailed investigation which might help 








SUMMARY AND CONCLUSION 
The aim of the present study was to estimate the circulatory and 
salivary levels of HSP 60 in periodontal health and disease and to assess 
whether they correlate with each other and with the systemic inflammatory 
marker, hs CRP. 45 patients who attended the out patient Department of 
periodontology, Ragas Dental College and Hospitals, Chennai were enrolled 
in the study.   Patients were divided in to two groups based on their 
periodontal health status- 22 Healthy patients, 23 Periodontitis patients. 
Peripheral blood and saliva was collected prior to phase I periodontal 
therapy from these patients and processed for ELISA  analysis. Processing for 
ELISA involved the preparation of cell lysates and serum from peripheral 
blood. Cell lysates were prepared by adding the extraction reagent provided in 
the HSP 60 ELISA kit to the lymphocytes separated from the peripheral blood.  
Statistical analysis was done using student t test and Pearson’s correlation 
From the results of this study, we may conclude that 
1) Periodontal disease results in an upregulation of circulating HSP 60 
levels and the systemic inflammatory marker-hs CRP, both of which 
correlate significantly with each other. 
2) Salivary HSP 60 has limited value as a biomarker of periodontal 
disease. Further, it correlates poorly with circulating HSP 60 levels and 
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